Neuropathix Financial Statements From 2010 to 2026
Neuropathix's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Neuropathix's valuation are provided below:Neuropathix does not presently have any fundamental ratios for analysis.
This module can also supplement various Neuropathix Technical models . Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in real.
Check Neuropathix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neuropathix's main balance sheet or income statement drivers, such as , as well as many indicators such as . Neuropathix financial statements analysis is a perfect complement when working with Neuropathix Valuation or Volatility modules.
Neuropathix |
Neuropathix OTC Stock Return On Asset Analysis
Neuropathix's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Neuropathix Return On Asset | -3.08 |
Most of Neuropathix's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neuropathix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Neuropathix has a Return On Asset of -3.081. This is 64.79% lower than that of the Healthcare sector and 86.94% lower than that of the Biotechnology industry. The return on asset for all United States stocks is notably higher than that of the company.
Neuropathix Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Neuropathix's current stock value. Our valuation model uses many indicators to compare Neuropathix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neuropathix competition to find correlations between indicators driving Neuropathix's intrinsic value. More Info.Neuropathix is rated below average in return on asset category among its peers. It is regarded fifth in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Neuropathix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Neuropathix's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Neuropathix OTC Stock
If you are still planning to invest in Neuropathix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neuropathix's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |